We are live on ! Find out more
UTMD icon

Utah Medical Products
UTMD

97 hedge funds and large institutions have $273M invested in Utah Medical Products in 2019 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 33 increasing their positions, 30 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

10% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 30

2.18% more ownership

Funds ownership: 74.31% → 76.49% (+2.2%)

2% more capital invested

Capital invested by funds: $266M → $273M (+$6.22M)

1% less funds holding

Funds holding: 98 → 97 (-1)

11% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 9

Holders
97
Holders Change
-1
Holders Change %
-1.02%
% of All Funds
2.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
33
Reduced
30
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ProShare Advisors
ProShare Advisors
Maryland
+$10.6M
2
Russell Investments Group
Russell Investments Group
United Kingdom
+$5.17M
3
DZ Bank
DZ Bank
Germany
+$1.05M
4
Invesco
Invesco
Georgia
+$826K
5
BlackRock
BlackRock
New York
+$784K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$5.62M
2
JP Morgan Chase
JP Morgan Chase
New York
-$2.08M
3
Renaissance Technologies
Renaissance Technologies
New York
-$1.02M
4
TAM
THB Asset Management
Connecticut
-$923K
5
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
-$737K
Name Holding Trade Value Shares
Change 		Change in
Stake
RhumbLine Advisers
51
RhumbLine Advisers
Massachusetts
$454K +$6.32K +68 +1%
TA
52
Teton Advisors
New York
$441K -$18.6K -200 -4%
CEP
53
Chicago Equity Partners
Illinois
$436K -$37.2K -400 -8%
FHB
54
First Hawaiian Bank
Hawaii
$411K – – –
AllianceBernstein
55
AllianceBernstein
Tennessee
$403K +$27.9K +300 +8%
New York State Common Retirement Fund
56
New York State Common Retirement Fund
New York
$383K – – –
PIM
57
Penobscot Investment Management
Massachusetts
$383K – – –
SCP
58
Seizert Capital Partners
Michigan
$342K – – –
Citadel Advisors
59
Citadel Advisors
Florida
$259K +$251K +2,704 New
Two Sigma Advisers
60
Two Sigma Advisers
New York
$249K +$18.6K +200 +8%
Barclays
61
Barclays
United Kingdom
$232K -$142K -1,524 -39%
Manulife (Manufacturers Life Insurance)
62
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$229K -$2.79K -30 -1%
Goldman Sachs
63
Goldman Sachs
New York
$216K +$1.67K +18 +0.8%
Deutsche Bank
64
Deutsche Bank
Germany
$213K -$150K -1,613 -42%
AIG
65
American International Group
New York
$211K -$1.39K -15 -0.7%
Morgan Stanley
66
Morgan Stanley
New York
$205K +$74.3K +799 +60%
HF
67
HRT Financial
New York
$203K +$198K +2,128 New
SRAM
68
Stone Ridge Asset Management
New York
$201K – – –
MIM
69
MetLife Investment Management
New Jersey
$192K – – –
PAM
70
Panagora Asset Management
Massachusetts
$162K – – –
OAM
71
Oppenheimer Asset Management
New York
$156K +$2.14K +23 +1%
Bank of America
72
Bank of America
North Carolina
$147K +$16.3K +175 +13%
Nisa Investment Advisors
73
Nisa Investment Advisors
Missouri
$140K +$125K +1,340 +1,117%
MLICM
74
Metropolitan Life Insurance Company (MetLife)
New York
$132K – – –
Victory Capital Management
75
Victory Capital Management
Texas
$130K +$126K +1,361 New
1 2
3
4 5

UTMD Hedge Fund Activity: Q3 2019 in Review

97 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Utah Medical Products (UTMD) for Q3 2019, worth a combined $273M — up 2.3% from $266M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of UTMD and 8 opened new positions — a net loss of 1 holder — while 30 trimmed existing stakes and 33 added.

The largest buyer was ProShare Advisors, opening a new position worth an estimated $10.6M. The largest seller was Fidelity Investments, cutting an estimated $5.62M.

  • 97 institutional investors held Utah Medical Products (UTMD) as of Q3 2019, down from 98 in Q2 2019.
  • Funds reported $273M of Utah Medical Products stock for Q3 2019, up 2.3% quarter-over-quarter.
  • 8 funds opened new Utah Medical Products positions in Q3 2019 and 9 closed out, a net change of -1 holder.
  • The largest Utah Medical Products buyer in Q3 2019 was ProShare Advisors, an estimated $10.6M added.
  • The largest Utah Medical Products seller in Q3 2019 was Fidelity Investments, an estimated $5.62M sold.

Based on aggregated 13F filings for Q3 2019.